Literature DB >> 3556195

The T cell-specific serine proteinase TSP-1 is associated with cytoplasmic granules of cytolytic T lymphocytes.

U Fruth, M Prester, J R Golecki, H Hengartner, H G Simon, M D Kramer, M M Simon.   

Abstract

This study describes the localization of the previously purified T cell-specific serine proteinase, termed TSP-1 (M. M. Simon et al., EMBO J. 1986. 5: 3267), within cytoplasmic granules of cytolytic T cell lines (CTLL). Subcellular fractionation of disintegrated CTLL (ruptured by nitrogen cavitation) was accomplished by Percoll density gradient centrifugation of cell lysates (postnuclear supernatant). Individual fractions were tested for proteinase activity on chromogenic peptide substrates and for the presence of TSP-1 by Western blot analysis. In addition, each fraction was assayed for cytolytic activity against sheep red blood cells (SRBC), for protein and for additional marker enzymes to assess the enrichment for cellular organells. All serine enzyme-type molecules including TSP-1 expressed by CTLL were identified by labeling cell lysates or gradient fractions with the serine proteinase-specific affinity ligand tritiated diisopropyl fluorophosphate [( 3H]DFP) in the presence or in the absence of class-specific or enzyme-specific proteinase inhibitors and subsequent sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The data demonstrate that the Percoll gradient fraction, which was shown by morphological examination in the electron microscope to be highly enriched for cytoplasmic granules, also contained greater than 80% of proteinase activity in addition to the granule-associated structures cytolysin and arylsulfatase. The identity of the granule-associated proteinase in two independent cell lines, CTLL HY3-Ag3 and CTLL 1.D.9, with the serine proteinase TSP-1 is indicated by its specificity for the chromogenic substrate H-D-Pro-Phe-Arg-p-nitroanilide, its sensitivity to class-specific as well as TSP-1-specific enzyme inhibitors and by its reactivity with a polyvalent TSP-1-specific rabbit antiserum. Both CTLL contain a [3H]DFP-labeled protein that migrates with a molecular mass of 60 kDa under nonreducing conditions and with 30 kDa under reducing conditions and which can be inactivated by the TSP-1-specific inhibitor H-D-Pro-Phe-Arg-chloromethylketone. CTLL HY3-Ag3 (a long-term culture CTLL with natural killer-like activity) but not CTLL 1.D.9 (an antigen-specific short-term cultured CTLL) express in addition a further [3H]DFP-binding protein which migrates with 27 kDa under nonreducing or reducing conditions. No substrate specificity was found for this molecule. The possible function of the granule-associated serine proteinase TSP-1 is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3556195     DOI: 10.1002/eji.1830170506

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  4 in total

1.  Cutaneous leishmaniasis: co-ordinate expression of granzyme A and lymphokines by CD4+ T cells from susceptible mice.

Authors:  S Frischholz; M Röllinghoff; H Moll
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

2.  Acid sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T lymphocytes.

Authors:  Jasmin Herz; Julian Pardo; Hamid Kashkar; Michael Schramm; Elza Kuzmenkina; Erik Bos; Katja Wiegmann; Reinhard Wallich; Peter J Peters; Stefan Herzig; Elmon Schmelzer; Martin Krönke; Markus M Simon; Olaf Utermöhlen
Journal:  Nat Immunol       Date:  2009-06-14       Impact factor: 25.606

3.  Rab27a is required for regulated secretion in cytotoxic T lymphocytes.

Authors:  J C Stinchcombe; D C Barral; E H Mules; S Booth; A N Hume; L M Machesky; M C Seabra; G M Griffiths
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

4.  Granzyme A-deficient mice retain potent cell-mediated cytotoxicity.

Authors:  K Ebnet; M Hausmann; F Lehmann-Grube; A Müllbacher; M Kopf; M Lamers; M M Simon
Journal:  EMBO J       Date:  1995-09-01       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.